Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells

Journal of Molecular Neuroscience

Volumn 42, Issue 3, 2010, Pages 450-458

  Brubel, R ^a   Boronkai, A ^a,b   Reglodi, D ^a   Racz, B ^b   Nemeth, J ^c   Kiss, P ^a   Lubics, A ^a   Toth, G ^d   Horvath, G ^a   Varga, T ^a   Szogyi, D ^a   Fonagy, E ^a   Farkas, J ^a   Barakonyi, A ^b   Bellyei, Sz ^a,b   Szereday, L ^b   Koppan, M ^a   Tamas, A ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Choriocarcinoma; JAR; Methotrexate; PACAP27; PACAP38; RIA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; METHOTREXATE;

ARTICLE; CANCER CELL; CELL ASSAY; CELL SURVIVAL; CELL VIABILITY; CHORIOCARCINOMA; CHORION VILLUS SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTROPHOBLAST; DECIDUA; DRUG EFFECT; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OUTCOME ASSESSMENT; PLACENTA; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHORIOCARCINOMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; RADIOIMMUNOASSAY; RANDOM ALLOCATION;

EID: 78349306904     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9374-5     Document Type: Article

References (45)

1. A Arimura A Somogyvari-Vigh A Miyata K Mizuno DH Coy C Kitada 1991 Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes Endocrinology 129 2787 2789 1:CAS:528:DyaK3MXmsVyntbY%3D 10.1210/endo-129-5-2787 1935809
2. N Aubert D Vaudry A Falluel-Morel, et al. 2008 PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway Neurobiol Dis 32 66 80 1:CAS:528:DC%2BD1cXhtFantbnF 10.1016/j.nbd.2008.06.014 18652895
3. A Boronkai R Brubel B Racz, et al. 2009 Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the survival and signal transduction pathways in human choriocarcinoma cells Ann NY Acad Sci 1163 353 357 1:CAS:528:DC%2BD1MXmvVWjsL4%3D 10.1111/j.1749-6632.2008.03630.x 19456358
4. A Castorina A Tiralongo S Giounta ML Carnazza G Rasi V D'Agata 2008 PACAP and VIP prevent apoptosis in schwannoma cells Brain Res 1241 29 35 1:CAS:528:DC%2BD1cXhtlyitbfL 10.1016/j.brainres.2008.09.035 18835258
5. R Counis JN Lavarriere G Garrel-Lazayres 2007 What is the role of PACAP in gonadotrope function? Peptides 28 1797 1804 1:CAS:528:DC%2BD2sXhtVWms7fM 10.1016/j.peptides.2007.05.011 17601637
6. BJ Desai JM Burrin 1994 PACAP-38 positively regulates glycoprotein hormone alpha-gene expression in placental cells Mol Cell Endocrinol 99 31 37 1:CAS:528:DyaK2cXhvVegurs%3D 10.1016/0303-7207(94)90143-0 7514549
7. D Farini A Puglianiello C Mammi G Siracusa C Moretti 2003 Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short-term and long-term exposure affect proliferation and neuroendocrine differentiation Endocrinology 144 1631 1643 1:CAS:528:DC%2BD3sXisVegt7k%3D 10.1210/en.2002-221009 12639948
8. B Gasz B Racz E Roth, et al. 2006 Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis Peptides 27 87 94 1:CAS:528:DC%2BD28Xktl2nug%3D%3D 10.1016/j.peptides.2005.06. 022 16095757
9. I Gutierrez-Canas N Rodriguez-Henche O Bolanos MJ Carmena JC Prieto MG Juarranz 2003 VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal Br J Pharmacol 139 1050 1058 1:CAS:528:DC%2BD3sXlvVCisrg%3D 10.1038/sj.bjp.0705317 12839880
10. A Hallmann J Klimek M Masaoka, et al. 2004 Partial characterization of human choriocarcinoma cell line JAR cells in regard to oxidative stress Acta Biochim Pol 51 1023 1038 1:CAS:528:DC%2BD2MXisFSnu7o%3D 15625574
11. J Hannibal E Ekblad H Mulder F Sundler J Fahrenkrug 1998 Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation Cell Tissue Res 291 65 79 1:CAS:528:DyaK1cXmvF2rtg%3D%3D 10.1007/s004410050980 9394044
12. N Hayez I Harfi R Lema-Kisoka M Svoboda F Corazza E Sariban 2004 The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells J Neuroimmunol 149 167 181 1:CAS:528: DC%2BD2cXitFChtbw%3D 10.1016/j.jneuroim.2003.12.008 15020077
13. L Hernadi P Zs T Kiss, et al. 2008 The presence and distribution of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor (PAC1-R) in the snail Helix pomatia Neuroscience 155 387 402 1:CAS:528:DC%2BD1cXhtVentr3O 10.1016/j.neuroscience.2008.05.003 18590802
14. E Hofsli L Thommesen F Yadetie, et al. 2005 Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells Br J Cancer 92 1506 1516 1:CAS:528:DC%2BD2MXjsVSjtrk%3D 10.1038/sj.bjc.6602535 15846300
15. ER Isaac NM Sherwood 2008 Pituitary adenylate cyclase activating polypeptide (PACAP) is important for embryo implantation in mice Mol Cell Endocrinol 280 13 19 1:CAS:528:DC%2BD2sXhsVWjtbvM 10.1016/j.mce.2007.09.003 17945412
16. B Jakab D Reglodi R Jozsa, et al. 2004 Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay J Biochem Biophys Meth 61 189 198 1:CAS:528:DC%2BD2cXhtVSktr%2FO 10.1016/j.jbbm.2004.03.002 15560935
17. F Jamen N Rodriguez-Henche F Pralong, et al. 2000 PAC1 null females display decreased fertility Ann NY Acad Sci 921 400 404 1:CAS:528: DC%2BD3MXntVaktA%3D%3D 10.1111/j.1749-6632.2000.tb07004.x 11193864
18. R Jozsa T Hollosy A Tamas G Toth I Lengvari D Reglodi 2005 Pituitary adenylate cyclase activating polypeptide plays a role in olfactory memory formation in chicken Peptides 26 2344 2350 1:CAS:528:DC%2BD2MXhtFylurvK 10.1016/j.peptides.2005.03.054 15927304
19. R Jozsa T Hollosy J Nemeth, et al. 2006 Presence of PACAP and VIP in embryonic chicken brain Ann NY Acad Sci 1070 348 353 1:CAS:528: DC%2BD28XpvVehtb4%3D 10.1196/annals.1317.039 16888190
20. P Kiss D Reglodi A Tamas, et al. 2007 Changes of PACAP levels in the brain show gender differences following short-term water and food deprivation Gen Comp Endocrinol 152 225 230 1:CAS:528:DC%2BD2sXmvV2hsrs%3D 10.1016/j.ygcen.2006.12.012 17286974
21. PO Koh SD Kwak HJ Kim, et al. 2003 Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta Mol Reprod Dev 64 27 31 1:CAS:528:DC%2BD38XptVelurY%3D 10.1002/mrd.10221 12420296
22. PO Koh CK Won HS Noh CJ Cho WS Choi 2005 Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta J Vet Sci 6 1 5 15785117
23. K Koves O Kantor J Molnar, et al. 2003 The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels J Mol Neurosci 20 141 152 10.1385/JMN:20:2:141 12794308
24. SV Le DJ Yamaguchi CA McArdle K Tachiki JR Pisegna P Germano 2002 PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells Regul Pept 109 115 125 1:CAS:528:DC%2BD38Xot1WrtL4%3D 10.1016/S0167-0115(02)00194-5 12409223
25. V Lelievre Z Hu JY Byun Y Ioffe JA Waschek 2002 Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition J Neurosci Res 67 566 573 1:CAS:528: DC%2BD38XisVKnsLk%3D 10.1002/jnr.10153 11891769
26. M Li S Cortez T Nakamachi V Batuman A Arimura 2006 Pituitary adenylate cyclase activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells Cancer Res 66 8796 8803 1:CAS:528:DC%2BD28XovF2hsbY%3D 10.1158/0008-5472.CAN-05-2809 16951196
27. A Miyata A Arimura RR Dahl, et al. 1989 Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem Biophys Res Commun 164 567 574 1:CAS:528:DyaK3cXps1Y%3D 10.1016/0006-291X(89)91757-9 2803320
28. J Nemeth B Jakab R Jozsa, et al. 2007 PACAP-27 radioimmunoassay: description and application of a novel method J Radioanal Nucl Chem 273 327 332 1:CAS:528:DC%2BD2sXntlequrg%3D 10.1007/s10967-007-6862-3
29. A Nicot E DiCicco-Bloom 2001 Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression Proc Natl Acad Sci USA 98 4758 4763 1:CAS:528:DC%2BD3MXjtVant7k%3D 10.1073/pnas.071465398 11296303
30. H Oka L Jin E Kulig BW Scheithauer RV Lloyd 1999 Pituitary adenylate cyclase activating polypeptide inhibits transforming growth factor-β1- induced apoptosis in a human pituitary adenoma cell line Am J Pathol 155 1893 1900 1:CAS:528:DC%2BD3cXit1Khuw%3D%3D 10595920
31. RE Papka M Workley S Usip CN Mowa J Fahrenkrug 2006 Expression of pituitary adenylate cyclase activating peptide in the uterine cervix, lumbosacral dorsal root ganglia and spinal cord of rats during pregnancy Peptides 27 743 752 1:CAS:528:DC%2BD28XjtFWqsrw%3D 10.1016/j.peptides.2005.08. 005 16181705
32. B Racz B Gasz B Borsiczky, et al. 2007 Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis Gen Comp Endocrinol 153 115 123 1:CAS:528: DC%2BD2sXotlSit7g%3D 10.1016/j.ygcen.2006.12.006 17270184
33. Racz B, Reglodi D, Horvath G et al (2010) Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture. J Mol Neurosci, in press
34. D Reglodi R Borzsei T Bagoly, et al. 2008 Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cells J Mol Neurosci 36 270 278 1:CAS:528:DC%2BD1cXhsVagtLjI 10.1007/s12031-008-9089-z 18607779
35. ML Scaldaferri A Modesti C Palumbo S Ulisse A Fabbri E Piccione G Frajese C Moretti 2000 Pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta Endocrinology 141 1158 1167 1:CAS:528:DC%2BD3cXisFOrtrk%3D 10.1210/en.141.3.1158 10698193
36. NM Sherwood BA Adams ER Isaac S Wu EA Fradinger 2007 Knocked down and out: PACAP in development, reproduction and feeding Peptides 28 1680 1687 1:CAS:528:DC%2BD2sXhtVWms7nJ 10.1016/j.peptides.2007.03.008 17467121
37. N Shintani W Mori H Hashimoto, et al. 2002 Defects in reproductive functions in PACAP-deficient female mice Regul Pept 109 45 48 1:CAS:528:DC%2BD38Xot1Wrsbc%3D 10.1016/S0167-0115(02)00169-6 12409213
38. A Somogyvari-Vigh D Reglodi 2004 Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide-review Curr Pharm Des 10 2861 2889 1:CAS:528:DC%2BD2cXmslKkuro%3D 10.2174/1381612043383548 15379674
39. F Spencer L Chi MX Zhu 2001 Temporal relationships among uterine pituitary adenylate cyclase activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats Comp Biochem Physiol C 129 25 34 1:STN:280: DC%2BD3M3ns12ltw%3D%3D
40. F Spencer L Chi MX Zhu 2001 A mechanistic assessment of 1, 3-butadiene diepoxide-induced inhibition of uterine deciduoma proliferation in pseudopregnant rats Reprod Toxicol 15 253 260 1:CAS:528:DC%2BD3MXktVOhsLk%3D 10.1016/S0890-6238(01)00121-6 11390169
41. BR Steenstrup JC Jorgensen P Alm, et al. 1996 Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit Regul Pept 61 197 204 1:CAS:528:DyaK28XjtFWit7w%3D 10.1016/0167-0115(95)00156-5 8701036
42. F Szabo J Horvath A Heinzlmann A Arimura K Koves 2002 Neonatal PACAP administration in rats delays puberty through the influence of the LHRH neuronal system Regul Pept 109 49 55 1:CAS:528:DC%2BD38Xot1Wrtrw%3D 10.1016/S0167- 0115(02)00185-4 12409214
43. D Vaudry A Falluel-Morel A Bourgault, et al. 2009 Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 283 357 10.1124/pr.109.001370 19805477
44. JA Waschek 2002 Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration Dev Neurosci 24 14 23 1:CAS:528:DC%2BD38Xls1Oqsro%3D 10.1159/000064942 12145407
45. F Zia M Fagarasan K Bitar, et al. 1995 Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells Cancer Res 55 4886 4891 1:CAS:528:DyaK2MXptFKiu7s%3D 7585525